Goldman Sachs’s Oramed Pharmaceuticals ORMP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-153,618
| Closed | -$401K | – | 4870 |
|
|
2023
Q3 | $401K | Buy |
153,618
+62,703
| +69% | +$164K | ﹤0.01% | 3972 |
|
|
2023
Q2 | $325K | Sell |
90,915
-10,039
| -10% | -$35.9K | ﹤0.01% | 4195 |
|
|
2023
Q1 | $220K | Buy |
100,954
+84,447
| +512% | +$184K | ﹤0.01% | 4484 |
|
|
2022
Q4 | $199K | Sell |
16,507
-38,395
| -70% | -$462K | ﹤0.01% | 4507 |
|
|
2022
Q3 | $355K | Buy |
54,902
+26,539
| +94% | +$172K | ﹤0.01% | 4455 |
|
|
2022
Q2 | $130K | Sell |
28,363
-41,820
| -60% | -$192K | ﹤0.01% | 5037 |
|
|
2022
Q1 | $607K | Sell |
70,183
-46,851
| -40% | -$405K | ﹤0.01% | 4448 |
|
|
2021
Q4 | $1.67M | Buy |
117,034
+97,266
| +492% | +$1.39M | ﹤0.01% | 3626 |
|
|
2021
Q3 | $435K | Sell |
19,768
-15,287
| -44% | -$336K | ﹤0.01% | 4457 |
|
|
2021
Q2 | $469K | Buy |
35,055
+15,300
| +77% | +$205K | ﹤0.01% | 4470 |
|
|
2021
Q1 | $201K | Buy |
+19,755
| New | +$201K | ﹤0.01% | 4843 |
|